Northern Trust Corp Aprea Therapeutics, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

Shares

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 12, 2022	SELL	$0.62 - $1.94 $306 - $960	-495 Reduced 1.69%	28,710 $22,000
Q1 2022 May 13, 2022	SELL	$1.59 - $3.16 $9,137 - $18,160	-5,747 Reduced 16.44%	29,205 $54,000
Q4 2021 Feb 08, 2022	SELL	$2.87 - $5.58 $1,308 - $2,544	-456 Reduced 1.29%	34,952 $100,000
Q3 2021 Nov 15, 2021	BUY	$3.43 - $5.63 $9,871 - $16,203	2,878 Added 8.85%	35,408 $181,000
Q2 2021 Aug 13, 2021	SELL	$4.05 - $5.5 $296,415 - $402,539	-73,189 Reduced 69.23%	32,530 $159,000
Q1 2021 May 12, 2021	SELL	$4.73 - $8.15 $36,444 - $62,795	-7,705 Reduced 6.79%	105,719 $539,000
Q4 2020 Feb 11, 2021	SELL	$4.92 - $30.67 $22,587 - $140,805	-4,591 Reduced 3.89%	113,424 $559,000
Q3 2020 Nov 16, 2020	BUY	$21.66 - $38.86 $154,869 - $277,849	7,150 Added 6.45%	118,015 $2.84 Million
Q2 2020 Aug 14, 2020	BUY	$25.47 - $39.69 $755,949 - $1.18 Million	29,680 Added 36.56%	110,865 $4.3 Million
Q1 2020 May 14, 2020	BUY	$31.65 - $45.3 $56,305 - $80,588	1,779 Added 2.24%	81,185 $2.82 Million
Q4 2019 Feb 14, 2020	BUY	$18.94 - $49.53 $1.5 Million - $3.93 Million	79,406 New	79,406 $3.64 Million

Others Institutions Holding APRE

# of Institutions

1

Shares Held

0

Call Options Held

0

Put Options Held

0

Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

About Aprea Therapeutics, Inc.

Ticker APRE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Description
Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel cancer therapeutics that target DNA damage response pathways. Its lead product candidate is ATRN-119, an oral ATR inhibitor that is in phase 1/2a clinical trial to treat patients with advanced solid tumors. The company's products...

More about APRE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.